-
As of 2006, the ongoing transmission of indigenous wild poliovirus (WPV) was limited to only four countries Afghanistan, Pakistan, India, and Nigeria.
-
In this issue: FDA issues multiple drug safety alerts; ARBs and cancer risk; and FDA actions.
-
As of june 29, 2011, german authorities reported 3,189 cases of entero-hemorrhagic E. coli (EHEC) infections, and 884 other cases have also been identified.
-
A 58-year-old liberian-born woman was in excellent general health, living and working in a large academic medical center in Rhode Island for more than 20 years when she developed nonspecific gastrointestinal symptoms and underwent endoscopy, which revealed Strongyloides stercoralis larvae on a duodenal biopsy in March 2010.
-
The increasingly close and almost intimate relationships with our pets can lead to increased numbers of cases and the emergence of zoonotic diseases, including human plague (Yersinia pestis).
-
The National Health Service in Britain in 2007 elected to ban traditional white coats and other long-sleeved garments for physicians in the workplace (including long-sleeved blouses and shirts). Subsequently, Scotland adopted similar policies. This decision was based on limited data suggesting that the cuffs and lower pockets of long-sleeved garments are more heavily colonized with bacteria than shorter garments.
-
Chronic fatigue syndrome, as defined by clinical symptoms, may improve with a combination of behavior therapy and graded exercise.
-
Using an algorithm based on score and chest x-ray when appropriate, the overall sensitivity for the detection of aortic dissection was 96%.
-
A new orally administered macrocylic antibiotic has been approved by the FDA for the treatment of Clostridium difficile infection. Fidaxomicin is a fermentation product of Dactylosporangium aurantiacum and is marketed by Optimer Pharmaceuticals, Inc., as Dificid.
-
It has recently been recognized that type 2 diabetes (DM2) increases risk for osteoporotic fracture, even though it has been demonstrated that DM2 is associated with a paradoxical increase in bone mineral density (BMD) compared to age-matched control populations. With a burgeoning prevalence of DM2 in the United States, almost 20% of the at-risk population for osteoporotic fracture has DM2, hence, clarification of risk stratification for this group is highly relevant.
